Skip to main content

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Investor Notice: Investigation over Potential Wrongdoing

San Diego, CA -- (SBWIRE) -- 03/08/2021 -- Certain directors of Sarepta Therapeutics, Inc are under investigation concerning potential breaches of fiduciary duties.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.